122 related articles for article (PubMed ID: 26097834)
41. Response to interferon therapy: influence of human leucocyte antigen alleles in patients with chronic hepatitis C.
Sim H; Wojcik J; Margulies M; Wade JA; Heathcote J
J Viral Hepat; 1998 Jul; 5(4):249-53. PubMed ID: 9751011
[TBL] [Abstract][Full Text] [Related]
42. The effect of HLA on immunological response to hepatitis B vaccine in healthy people: a meta-analysis.
Li ZK; Nie JJ; Li J; Zhuang H
Vaccine; 2013 Sep; 31(40):4355-61. PubMed ID: 23887040
[TBL] [Abstract][Full Text] [Related]
43. Curative effects of interferon-alpha and HLA-DRB1 -DQA1 and -DQB1 alleles in chronic viral hepatitis B.
Zang GQ; Xi M; Feng ML; Ji Y; Yu YS; Tang ZH
World J Gastroenterol; 2004 Jul; 10(14):2116-8. PubMed ID: 15237447
[TBL] [Abstract][Full Text] [Related]
44. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research.
Thursz M; Yallop R; Goldin R; Trepo C; Thomas HC
Lancet; 1999 Dec 18-25; 354(9196):2119-24. PubMed ID: 10609818
[TBL] [Abstract][Full Text] [Related]
45. HLA-DRB1 and DQB1 alleles in Japanese type 1 autoimmune hepatitis: The predisposing role of the DR4/DR8 heterozygous genotype.
Oka S; Furukawa H; Yasunami M; Kawasaki A; Nakamura H; Nakamura M; Komori A; Abiru S; Nagaoka S; Hashimoto S; Naganuma A; Naeshiro N; Yoshizawa K; Yamashita H; Ario K; Ohta H; Sakai H; Yabuuchi I; Takahashi A; Abe K; Yatsuhashi H; Tohma S; Ohira H; Tsuchiya N; Migita K
PLoS One; 2017; 12(10):e0187325. PubMed ID: 29088299
[TBL] [Abstract][Full Text] [Related]
46. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B.
Jiang YG; Wang YM; Liu TH; Liu J
World J Gastroenterol; 2003 Oct; 9(10):2221-5. PubMed ID: 14562382
[TBL] [Abstract][Full Text] [Related]
47. Low frequency of HLA DRB1*03 - DQB1*02 and DQB1*0302 haplotypes in Romania is consistent with the country's low incidence of Type I diabetes.
Ionescu-Tîrgoviste C; Guja C; Herr M; Cucca E; Welsh K; Bunce M; Marshall S; Todd JA
Diabetologia; 2001 Oct; 44 Suppl 3():B60-6. PubMed ID: 11724419
[TBL] [Abstract][Full Text] [Related]
48. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
49. Immunogenetic Background of Chronic Lymphoproliferative Disorders in Romanian Patients-Case Control Study.
Tizu M; Calenic B; Maruntelu I; Caragea AM; Talangescu A; Ursu L; Rotarescu C; Surugiu M; Constantinescu AE; Constantinescu I
Med Sci (Basel); 2024 Feb; 12(1):. PubMed ID: 38535155
[TBL] [Abstract][Full Text] [Related]
50. Association of HLA alleles with hepatitis C infection in Maharashtra, western India.
Tripathy AS; Shankarkumar U; Chadha MS; Ghosh K; Arankalle VA
Indian J Med Res; 2009 Nov; 130(5):550-5. PubMed ID: 20090103
[TBL] [Abstract][Full Text] [Related]
51. HLA-DQA1 & DQB1 variants associated with hepatitis B virus-related chronic hepatitis, cirrhosis & hepatocellular carcinoma.
Karra VK; Chowdhury SJ; Ruttala R; Gumma PK; Polipalli SK; Chakravarti A; Kar P
Indian J Med Res; 2018 Jun; 147(6):573-580. PubMed ID: 30168489
[TBL] [Abstract][Full Text] [Related]
52. Lack of a strong association between HLA class II, tumour necrosis factor and transporter associated with antigen processing gene polymorphisms and virological response to alpha-interferon treatment in patients with chronic hepatitis C.
Airoldi A; Zavaglia C; Silini E; Tinelli C; Martinetti M; Asti M; Rossini A; Vangeli M; Salvaneschi L; Pinzello G
Eur J Immunogenet; 2004 Dec; 31(6):259-65. PubMed ID: 15548263
[TBL] [Abstract][Full Text] [Related]
53. [HLA class II alleles and response to hepatitis C treatment with interferon alpha2b].
Piekarska A; Woszczek G; Sidorkiewicz M; Kuydowicz J
Przegl Epidemiol; 2002; 56(1):123-8. PubMed ID: 12150055
[TBL] [Abstract][Full Text] [Related]
54. Associations of human leucocyte antigen class II-DQB1 alleles with hepatitis C virus infection in Egyptian population: a multicentre family-based study.
El-Bendary M; Neamatallah M; Esmat G; Kamel E; Elalfy H; Besheer T; Eldeib D; Eladl AH; El-Setouhy M; El-Gilany AH; El-Waseef A
J Viral Hepat; 2016 Dec; 23(12):961-970. PubMed ID: 27599887
[TBL] [Abstract][Full Text] [Related]
55. HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?
Peano G; Menardi G; Ponzetto A; Fenoglio LM
Arch Intern Med; 1994 Dec 12-26; 154(23):2733-6. PubMed ID: 7993158
[TBL] [Abstract][Full Text] [Related]
56. Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease.
Hüe S; Cacoub P; Renou C; Halfon P; Thibault V; Charlotte F; Picon M; Rifflet H; Piette JC; Pol S; Caillat-Zucman S
J Infect Dis; 2002 Jul; 186(1):106-9. PubMed ID: 12089669
[TBL] [Abstract][Full Text] [Related]
57. Influence of HLA-DRB1 alleles and HBV genotypes on interferon-alpha therapy for chronic hepatitis B.
Chu RH; Ma LX; Wang G; Shao LH
World J Gastroenterol; 2005 Aug; 11(30):4753-7. PubMed ID: 16094724
[TBL] [Abstract][Full Text] [Related]
58. Relationship between HLA-DRB1*0101, DRB1*0301 alleles and interleukin-12 in haemophilic patients and hepatitis C virus positive hepatocellular carcinoma patients.
Hamed NA; Hano AF; Raouf HA; Gamal M; Eissa M
Egypt J Immunol; 2003; 10(1):17-26. PubMed ID: 15719619
[TBL] [Abstract][Full Text] [Related]
59. Influence of HLA alleles in response to treatment with pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C.
Marangon AV; Moliterno RA; Sell AM; de Moraes CF; Grotto RM; Pardini MC; De Pauli DS; Visentainer JE; Silva GF
Int J Immunogenet; 2012 Aug; 39(4):296-302. PubMed ID: 22284614
[TBL] [Abstract][Full Text] [Related]
60. Frequency of the Main Human Leukocyte Antigen A, B, DR, and DQ Loci Known to Be Associated with the Clearance or Persistence of Hepatitis C Virus Infection in a Healthy Population from the Southern Region of Morocco: A Preliminary Study.
Machraoui S; Errafii K; Oujamaa I; Belghali MY; Hakmaoui A; Lamjadli S; Eddehbi FE; Brahim I; Haida Y; Admou B
Diseases; 2024 May; 12(5):. PubMed ID: 38785761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
